scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1034271844 |
P356 | DOI | 10.1007/S00405-011-1647-2 |
P698 | PubMed publication ID | 21626121 |
P50 | author | Christine Adrion | Q50285744 |
P2093 | author name string | Michael Strupp | |
Ulrich Mansmann | |||
Klaus Jahn | |||
Franziska Lezius | |||
P2860 | cites work | Betahistine for Menière's disease or syndrome. | Q30661909 |
Betahistine: a retrospective synopsis of safety data | Q31069695 | ||
Clinical and epidemiological study of vertigo at an outpatient clinic. | Q35672344 | ||
Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? | Q36033980 | ||
Long-term prophylactic treatment of attacks of vertigo in Menière's disease--comparison of a high with a low dosage of betahistine in an open trial | Q46637476 | ||
Psychiatric comorbidity in different organic vertigo syndromes. | Q51892852 | ||
Psychological assessment of patients with Menière's disease. | Q51912183 | ||
The interrelations of migraine, vertigo, and migrainous vertigo. | Q52966238 | ||
Episodic vertigo related to migraine (90 cases): vestibular migraine? | Q53341865 | ||
Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc | Q72060598 | ||
Meniere's disease | Q81733714 | ||
P433 | issue | 8 | |
P304 | page(s) | 1237-1240 | |
P577 | publication date | 2011-05-29 | |
P1433 | published in | European Archives of Oto-Rhino-Laryngology | Q2624005 |
P1476 | title | High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Menière's disease: a case series | |
P478 | volume | 268 |
Q28081399 | Association of cinnarizine and betahistine in prophylactic therapy for Ménière's disease with and without migraine |
Q55407927 | Betahistine Treatment in a Cat Model of Vestibular Pathology: Pharmacokinetic and Pharmacodynamic Approaches. |
Q34321223 | Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo |
Q89729736 | Betahistine, prevents kindling, ameliorates the behavioral comorbidities and neurodegeneration induced by pentylenetetrazole |
Q45502246 | Cardinal symptom vertigo from the neurologist's perspective |
Q43925111 | Dizziness from the viewpoint of otorhinolaryngology |
Q34035274 | Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience |
Q56672452 | Effect of standard-dose Betahistine on endolymphatic hydrops: an MRI pilot study |
Q35026152 | Effects and safety profile of betahistine in patients in the Russian contingent of OSVaLD, an open-label observational study in vestibular vertigo |
Q34661826 | Effects and tolerability of betahistine in patients with vestibular vertigo: results from the Romanian contingent of the OSVaLD study. |
Q28602238 | Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial) |
Q91754507 | European Position Statement on Diagnosis, and Treatment of Meniere's Disease |
Q93378595 | Good Clinical Approach: Delphi Consensus for the Use of Betahistine in Menière's Disease |
Q52659022 | Menière's disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study. |
Q26827285 | The link between allergy and Menière's disease |
Q37118909 | The treatment and natural course of peripheral and central vertigo |
Q47989461 | Treatment of Menière's Disease |
Q44889838 | Vertigo and dizziness: the neurologist's perspective |